xLM - Continuous Intelligence published a new Forbes Technology Council article titled The Self-Driving Pharmaceutical Company.

Pharma does not need more AI demos. Pharma needs AI that can survive validation, inspection, audit, and real-world operations. That is the problem we work on every day. At xLM Continuous Intelligence we help pharmaceutical, biotech, and medical device companies adopt AI/ML and agentic applications inside GxP processes. Our work sits at the intersection of artificial intelligence, computer system validation, data integrity, cloud compliance, FDA CSA, 21 CFR Part 11, Annex 11, and regulated manufacturing. For more than 10 years, we have helped life sciences companies modernize regulated technology environments. Founded in 2016 to address the next major shift: continuous, AI-enabled compliance. The regulated world has a brutal problem. Business teams want speed. Quality teams need evidence. IT teams need scalable architecture. Regulators expect control, traceability, and accountability. Most AI programs fail because they treat compliance as documentation added at the end. xLM takes the opposite approach. We build and support AI-enabled GxP applications with validation, governance, monitoring, and lifecycle control designed in from the beginning. Our Continuous Intelligence platform and managed services support: ☑️Continuous Intelligent Validation ☑️AI agents for regulated workflows ☑️CSV-to-CSA transformation ☑️GxP data integrity ☑️Real-time compliance monitoring ☑️Predictive maintenance ☑️Temperature mapping ☑️21 CFR Part 11 and Annex 11 / Annex 22 readiness The objective is not “AI adoption.” The objective is compliant operational intelligence: lower validation cost, faster implementation, stronger inspection readiness, better process control, and less dependence on manual compliance work.

Founded 2015